Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-02

FDA Approved: LAMIVUDINE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s original application for a generic lamivudine product (ANDA 202941). The generic is approved for the same indications as the referen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)